Evidence map›Paper›PMID 36142422›Full record

ArticleInternational journal of molecular sciences2022

Thebromine Targets Adenosine Receptors to Control Hippocampal Neuronal Function and Damage.

Pedro Valada, Sofia Alçada-Morais, Rodrigo A Cunha, João Pedro Lopes

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Aberrant adenosine ANature communications · 2025
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Pedro ValadaCNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal.ORCID 0000-0002-6625-2572
Sofia Alçada-MoraisCNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal.
Rodrigo A CunhaCNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal.ORCID 0000-0003-2550-6422
João Pedro LopesCNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal.
University of Coimbra · PT

Funding

Centro 2020 CENTRO-01-0246-FEDER-000010Fundação para a Ciência e Tecnologia POCI-01-0145-FEDER-031274Fundação para a Ciência e Tecnologia UIDB/04539/2020La Caixa Banking Foundation LCF/PR/HP17/52190001
6 · The paper itself

Abstract

Theobromine is a caffeine metabolite most abundant in dark chocolate, of which consumption is linked with a lower risk of cognitive decline. However, the mechanisms through which theobromine affects neuronal function remain ill-defined. Using electrophysiological recordings in mouse hippocampal synapses, we now characterized the impact of a realistic concentration of theobromine on synaptic transmission and plasticity. Theobromine (30 μM) facilitated synaptic transmission while decreasing the magnitude of long-term potentiation (LTP), with both effects being blunted by adenosine deaminase (2 U/mL). The pharmacological blockade of A

Indexed as

Adenosine DeaminaseCaffeineAnimalsHippocampusMiceNeuronal PlasticityReceptor, Adenosine A2ASynapsesTheobromineAdenosine DeaminaseCaffeineReceptor, Adenosine A2ATheobromineadenosine receptorsAlzheimer’s diseasecaffeinesynaptic plasticitysynaptic transmissiontheobromine

Identifiers

PMID36142422
PMCPMC9502181
OpenAlexW4296801431

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.